首页> 美国卫生研究院文献>Patient preference and adherence >Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

【2h】

Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

机译：用图坦古柯阿尔法聚乙二醇（N8-GP）治疗的血友病A患者的健康相关生活质量和治疗满意度：新型重组延长的半衰期FVIII

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundProphylactic treatment regimens lead to improvements in health-related quality-of-life (HRQoL) among individuals with hemophilia. Turoctocog alfa pegol (N8-GP) provides the benefit of extending the duration of protection from bleeding and reducing the number of injections, which is expected to impact HRQoL and treatment satisfaction (TS).

机译：背景预防性治疗方案可改善血友病患者健康相关的生活质量（HRQoL）。 Turoctocog alfa pegol（N8-GP）的好处是延长了防止出血的持续时间并减少了注射次数，这有望影响HRQoL和治疗满意度（TS）。

著录项

期刊名称 Patient preference and adherence
作者
Susan Kearney; Leslie J Raffini; Tan P Pham; Xin Ying Lee; Sylvia von Mackensen; Andrea Landorph; Hideyuki Takedani; Johannes Oldenburg;
展开▼
作者单位

展开▼
年(卷),期 2019(13),-1
年度 2019
页码 497–513
总页数 17
原文格式 PDF
正文语种
中图分类基础医学;
关键词
hemophilia A turoctocog alfa pegol health-related quality-of-life children adults treatment satisfaction;

机译：甲型血友病;阿尔法Turoctocog聚乙二醇;与健康相关的生活质量;儿童;成人;治疗满意度;

相似文献

外文文献
中文文献
专利

1. Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII [J] . Susan Kearney, Leslie J Raffini, Tan P Pham, Patient Preference and Adherence . 2019,第1期

机译：用图坦柯克阿尔法聚乙二醇（N8-GP）治疗的血友病A患者的健康相关生活质量和治疗满意度：新型重组延长的半衰期FVIII
2. Intravenous Administration of Recombinant Factor VIII Induces Immune Tolerance to Subcutaneous Turoctocog Alfa Pegol (SC N8-GP) in Humanized Hemophilia A Mice [J] . Reedtz-Runge Stine Louise, Weldingh Karin, Schultz Heidi Schioler, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：重组因子VIII的静脉内给药诱导人源化血友病中的皮下Turoctocog Alfa Pegol（SC N8-GP）的免疫耐受性
3. Plasma Polyethylene Glycol (PEG) Levels Reach Steady State Following Repeated Treatment with N8-GP (Turoctocog Alfa Pegol; Esperoct) [J] . Nature reviews Cancer . 2020,第2期

机译：血浆聚乙二醇（PEG）水平在用N8-GP（Turoctocog Alfa Pegol; esperoct）反复处理后达到稳态
4. Plasma Polyethylene Glycol (PEG) Levels Reach Steady State Following Repeated Treatment with N8-GP (Turoctocog Alfa Pegol; Esperoct®) [O] . Inga Bjørnsdottir, Birgitte Støvring, Tue Søeborg, 2020

机译：反复用N8-GP（Turoctocog Alfa Pegol;Esperoct®）处理后血浆聚乙二醇（PEG）水平达到稳态
5. Recombinant FVIII Products (Turoctocog Alfa and Turoctocog Alfa Pegol) Stable Up to 40°C [O] . Mariasanta Napolitano, Arne Agerlin Olsen, Anne Mette Nøhr, 2021

机译：重组FVIII产品（Turoctocog Alfa和Turoctocog Alfa Pegol）稳定达40°C

Health-related quality-of-life and treatment satisfaction of individuals with hemophilia A treated with turoctocog alfa pegol (N8-GP): a new recombinant extended half-life FVIII

摘要

著录项

相似文献

相关主题

期刊订阅